Cargando…

Postischemic cardiac recovery in heme oxygenase-1 transgenic ischemic/reperfused mouse myocardium

Heme oxygenase-1 (HO-1) transgenic mice (Tg) were created using a rat HO-1 genomic transgene. Transgene expression was detected by RT-PCR and Western blots in the left ventricle (LV), right ventricle (RV) and septum (S) in mouse hearts, and its function was demonstrated by the elevated HO enzyme act...

Descripción completa

Detalles Bibliográficos
Autores principales: Juhasz, Bela, Varga, Balazs, Czompa, Attila, Bak, Istvan, Lekli, Istvan, Gesztelyi, Rudolf, Zsuga, Judit, Kemeny-Beke, Adam, Antal, Miklos, Szendrei, Levente, Tosaki, Arpad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3918052/
https://www.ncbi.nlm.nih.gov/pubmed/20716121
http://dx.doi.org/10.1111/j.1582-4934.2010.01153.x
_version_ 1782302915805839360
author Juhasz, Bela
Varga, Balazs
Czompa, Attila
Bak, Istvan
Lekli, Istvan
Gesztelyi, Rudolf
Zsuga, Judit
Kemeny-Beke, Adam
Antal, Miklos
Szendrei, Levente
Tosaki, Arpad
author_facet Juhasz, Bela
Varga, Balazs
Czompa, Attila
Bak, Istvan
Lekli, Istvan
Gesztelyi, Rudolf
Zsuga, Judit
Kemeny-Beke, Adam
Antal, Miklos
Szendrei, Levente
Tosaki, Arpad
author_sort Juhasz, Bela
collection PubMed
description Heme oxygenase-1 (HO-1) transgenic mice (Tg) were created using a rat HO-1 genomic transgene. Transgene expression was detected by RT-PCR and Western blots in the left ventricle (LV), right ventricle (RV) and septum (S) in mouse hearts, and its function was demonstrated by the elevated HO enzyme activity. Tg and non-transgenic (NTg) mouse hearts were isolated and subjected to ischemia/reperfusion. Significant post-ischemic recovery in coronary flow (CF), aortic flow (AF), aortic pressure (AOP) and first derivative of AOP (AOPdp/dt) were detected in the HO-1 Tg group compared to the NTg values. In HO-1 Tg hearts treated with 50 μmol/kg of tin protoporphyrin IX (SnPPIX), an HO enzyme inhibitor, abolished the post-ischemic cardiac recovery. HO-1 related carbon monoxide (CO) production was detected in NTg, HO-1 Tg and HO-1 Tg + SnPPIX treated groups, and a substantial increase in CO production was observed in the HO-1 Tg hearts subjected to ischemia/reperfusion. Moreover, in ischemia/reperfusion-induced tissue Na(+) and Ca(2+) gains were reduced in HO-1 Tg group in comparison with the NTg and HO-1 Tg + SnPPIX treated groups; furthermore K(+) loss was reduced in the HO-1 Tg group. The infarct size was markedly reduced from its NTg control value of 37 ± 4% to 20 ± 6% (P < 0.05) in the HO-1 Tg group, and was increased to 47 ± 5% (P < 0.05) in the HO-1 knockout (KO) hearts. Parallel to the infarct size reduction, the incidence of total and sustained ventricular fibrillation were also reduced from their NTg control values of 92% and 83% to 25% (P < 0.05) and 8% (P < 0.05) in the HO-1 Tg group, and were increased to 100% and 100% in HO-1 KO(−/−) hearts. Immunohistochemical staining of HO-1 was intensified in HO-1 Tg compared to the NTg myocardium. Thus, the HO-1 Tg mouse model suggests a valuable therapeutic approach in the treatment of ischemic myocardium.
format Online
Article
Text
id pubmed-3918052
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-39180522015-04-06 Postischemic cardiac recovery in heme oxygenase-1 transgenic ischemic/reperfused mouse myocardium Juhasz, Bela Varga, Balazs Czompa, Attila Bak, Istvan Lekli, Istvan Gesztelyi, Rudolf Zsuga, Judit Kemeny-Beke, Adam Antal, Miklos Szendrei, Levente Tosaki, Arpad J Cell Mol Med Articles Heme oxygenase-1 (HO-1) transgenic mice (Tg) were created using a rat HO-1 genomic transgene. Transgene expression was detected by RT-PCR and Western blots in the left ventricle (LV), right ventricle (RV) and septum (S) in mouse hearts, and its function was demonstrated by the elevated HO enzyme activity. Tg and non-transgenic (NTg) mouse hearts were isolated and subjected to ischemia/reperfusion. Significant post-ischemic recovery in coronary flow (CF), aortic flow (AF), aortic pressure (AOP) and first derivative of AOP (AOPdp/dt) were detected in the HO-1 Tg group compared to the NTg values. In HO-1 Tg hearts treated with 50 μmol/kg of tin protoporphyrin IX (SnPPIX), an HO enzyme inhibitor, abolished the post-ischemic cardiac recovery. HO-1 related carbon monoxide (CO) production was detected in NTg, HO-1 Tg and HO-1 Tg + SnPPIX treated groups, and a substantial increase in CO production was observed in the HO-1 Tg hearts subjected to ischemia/reperfusion. Moreover, in ischemia/reperfusion-induced tissue Na(+) and Ca(2+) gains were reduced in HO-1 Tg group in comparison with the NTg and HO-1 Tg + SnPPIX treated groups; furthermore K(+) loss was reduced in the HO-1 Tg group. The infarct size was markedly reduced from its NTg control value of 37 ± 4% to 20 ± 6% (P < 0.05) in the HO-1 Tg group, and was increased to 47 ± 5% (P < 0.05) in the HO-1 knockout (KO) hearts. Parallel to the infarct size reduction, the incidence of total and sustained ventricular fibrillation were also reduced from their NTg control values of 92% and 83% to 25% (P < 0.05) and 8% (P < 0.05) in the HO-1 Tg group, and were increased to 100% and 100% in HO-1 KO(−/−) hearts. Immunohistochemical staining of HO-1 was intensified in HO-1 Tg compared to the NTg myocardium. Thus, the HO-1 Tg mouse model suggests a valuable therapeutic approach in the treatment of ischemic myocardium. Blackwell Publishing Ltd 2011-09 2011-08-28 /pmc/articles/PMC3918052/ /pubmed/20716121 http://dx.doi.org/10.1111/j.1582-4934.2010.01153.x Text en © 2011 The Authors Journal compilation © 2011 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
spellingShingle Articles
Juhasz, Bela
Varga, Balazs
Czompa, Attila
Bak, Istvan
Lekli, Istvan
Gesztelyi, Rudolf
Zsuga, Judit
Kemeny-Beke, Adam
Antal, Miklos
Szendrei, Levente
Tosaki, Arpad
Postischemic cardiac recovery in heme oxygenase-1 transgenic ischemic/reperfused mouse myocardium
title Postischemic cardiac recovery in heme oxygenase-1 transgenic ischemic/reperfused mouse myocardium
title_full Postischemic cardiac recovery in heme oxygenase-1 transgenic ischemic/reperfused mouse myocardium
title_fullStr Postischemic cardiac recovery in heme oxygenase-1 transgenic ischemic/reperfused mouse myocardium
title_full_unstemmed Postischemic cardiac recovery in heme oxygenase-1 transgenic ischemic/reperfused mouse myocardium
title_short Postischemic cardiac recovery in heme oxygenase-1 transgenic ischemic/reperfused mouse myocardium
title_sort postischemic cardiac recovery in heme oxygenase-1 transgenic ischemic/reperfused mouse myocardium
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3918052/
https://www.ncbi.nlm.nih.gov/pubmed/20716121
http://dx.doi.org/10.1111/j.1582-4934.2010.01153.x
work_keys_str_mv AT juhaszbela postischemiccardiacrecoveryinhemeoxygenase1transgenicischemicreperfusedmousemyocardium
AT vargabalazs postischemiccardiacrecoveryinhemeoxygenase1transgenicischemicreperfusedmousemyocardium
AT czompaattila postischemiccardiacrecoveryinhemeoxygenase1transgenicischemicreperfusedmousemyocardium
AT bakistvan postischemiccardiacrecoveryinhemeoxygenase1transgenicischemicreperfusedmousemyocardium
AT lekliistvan postischemiccardiacrecoveryinhemeoxygenase1transgenicischemicreperfusedmousemyocardium
AT gesztelyirudolf postischemiccardiacrecoveryinhemeoxygenase1transgenicischemicreperfusedmousemyocardium
AT zsugajudit postischemiccardiacrecoveryinhemeoxygenase1transgenicischemicreperfusedmousemyocardium
AT kemenybekeadam postischemiccardiacrecoveryinhemeoxygenase1transgenicischemicreperfusedmousemyocardium
AT antalmiklos postischemiccardiacrecoveryinhemeoxygenase1transgenicischemicreperfusedmousemyocardium
AT szendreilevente postischemiccardiacrecoveryinhemeoxygenase1transgenicischemicreperfusedmousemyocardium
AT tosakiarpad postischemiccardiacrecoveryinhemeoxygenase1transgenicischemicreperfusedmousemyocardium